NASDAQ:SMLR Semler Scientific (SMLR) Stock Price, News & Analysis $29.64 -0.99 (-3.23%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$29.61 -0.03 (-0.10%) As of 08/29/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Semler Scientific Stock (NASDAQ:SMLR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Semler Scientific alerts:Sign Up Key Stats Today's Range$29.31▼$30.7050-Day Range$29.64▼$45.9752-Week Range$21.77▼$81.56Volume483,376 shsAverage Volume558,294 shsMarket Capitalization$438.82 millionP/E Ratio12.20Dividend YieldN/APrice Target$81.75Consensus RatingBuy Company Overview Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. Read More Semler Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks64th Percentile Overall ScoreSMLR MarketRank™: Semler Scientific scored higher than 64% of companies evaluated by MarketBeat, and ranked 359th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingSemler Scientific has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageSemler Scientific has only been the subject of 3 research reports in the past 90 days.Read more about Semler Scientific's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Semler Scientific is 12.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 271.12.Price to Earnings Ratio vs. SectorThe P/E ratio of Semler Scientific is 12.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 83.67.Price to Book Value per Share RatioSemler Scientific has a P/B Ratio of 1.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Semler Scientific's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted20.47% of the float of Semler Scientific has been sold short.Short Interest Ratio / Days to CoverSemler Scientific has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Semler Scientific has recently decreased by 5.38%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSemler Scientific does not currently pay a dividend.Dividend GrowthSemler Scientific does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted20.47% of the float of Semler Scientific has been sold short.Short Interest Ratio / Days to CoverSemler Scientific has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Semler Scientific has recently decreased by 5.38%, indicating that investor sentiment is improving significantly. News and Social Media2.1 / 5News Sentiment0.76 News SentimentSemler Scientific has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.11 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Semler Scientific this week, compared to 5 articles on an average week.Search InterestOnly 10 people have searched for SMLR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Semler Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Semler Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders16.40% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions49.37% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Semler Scientific's insider trading history. Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SMLR Stock News HeadlinesSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law FirmAugust 29 at 6:01 PM | prnewswire.comInvestor Alert: Robbins LLP Informs Investors that a Class Action Lawsuit Has Been Filed Against Semler Scientific, Inc.August 29 at 5:14 PM | prnewswire.comWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.September 1 at 2:00 AM | Stansberry Research (Ad)SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 29 at 4:56 PM | businesswire.comSemler Scientific, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; October 28, 2025 Deadline to file Lead Plaintiff MotionAugust 29 at 4:23 PM | globenewswire.comEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors - SMLRAugust 29 at 4:09 PM | tmcnet.comEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors – SMLRAugust 29 at 1:17 PM | businesswire.comWitnessing An Insider Decision, Douglas Murphy-Chutorian Exercises Options Valued At $1.68M At Semler ScientificAugust 27, 2025 | benzinga.comSee More Headlines SMLR Stock Analysis - Frequently Asked Questions How have SMLR shares performed this year? Semler Scientific's stock was trading at $54.00 at the beginning of the year. Since then, SMLR stock has decreased by 45.1% and is now trading at $29.64. How were Semler Scientific's earnings last quarter? Semler Scientific Inc. (NASDAQ:SMLR) issued its quarterly earnings results on Monday, August, 4th. The company reported $5.04 earnings per share for the quarter, beating the consensus estimate of ($0.27) by $5.31. The business had revenue of $8.22 million for the quarter, compared to the consensus estimate of $8.10 million. Semler Scientific had a net margin of 86.20% and a trailing twelve-month return on equity of 43.84%. Read the conference call transcript. Who are Semler Scientific's major shareholders? Top institutional shareholders of Semler Scientific include Interchange Capital Partners LLC (9.31%), Geode Capital Management LLC (1.45%), Deltec Asset Management LLC (0.74%) and Raymond James Financial Inc. (0.55%). Insiders that own company stock include Eric Semler and Douglas Murphy-Chutorian. View institutional ownership trends. How do I buy shares of Semler Scientific? Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Semler Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Semler Scientific investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Arista Networks (ANET) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings8/04/2025Today9/01/2025Next Earnings (Estimated)11/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SMLR CIK1554859 Webwww.semlerscientific.com Phone877-774-4211FaxN/AEmployees120Year FoundedN/APrice Target and Rating Average Price Target for Semler Scientific$81.75 High Price Target$101.00 Low Price Target$60.00 Potential Upside/Downside+175.8%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$2.43 Trailing P/E Ratio12.20 Forward P/E RatioN/A P/E GrowthN/ANet Income$40.90 million Net Margins86.20% Pretax Margin103.88% Return on Equity43.84% Return on Assets32.88% Debt Debt-to-Equity Ratio0.25 Current Ratio0.60 Quick Ratio0.58 Sales & Book Value Annual Sales$42.98 million Price / Sales10.21 Cash Flow$4.48 per share Price / Cash Flow6.62 Book Value$24.90 per share Price / Book1.19Miscellaneous Outstanding Shares14,805,000Free Float12,377,000Market Cap$438.82 million OptionableNot Optionable Beta1.39 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:SMLR) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.